Approval · Notice of Compliance 4530 · 1996

ALTI-MPA: Notice of Compliance 4530

Issued October 4, 1996

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 4530
Date: October 4, 1996
Company: Altimed Pharmaceutical Company Inc., Division Of Technilab Pharma Inc.
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Therapeutic class: Progestin

Products in this notice

Brand	DIN	Status today
ALTI-MPA	02148552	Cancelled Post Market
ALTI-MPA	02148560	Cancelled Post Market
ALTI-MPA	02148579	Cancelled Post Market

Medicinal ingredients

MEDROXYPROGESTERONE ACETATE 2.5 MG per TAB
MEDROXYPROGESTERONE ACETATE 5 MG per TAB
MEDROXYPROGESTERONE ACETATE 10 MG per TAB